Naruhiro Kayukawa

CNPY2 inhibits MYLIP-mediated AR protein degradation in prostate cancer cells

K. Okihara, O. Ukimura, F. Hongo, 2018, Oncotarget.

A genetic screen in Drosophila for regulators of human prostate cancer progression.

T. Miki, A. Ueno, Saya Ito, 2014, Biochemical and biophysical research communications.

CNPY2 promoted the proliferation of renal cell carcinoma cells and increased the expression of TP53.

O. Ukimura, F. Hongo, A. Ueno, 2017, Biochemical and biophysical research communications.

MRGBP promotes AR-mediated transactivation of KLK3 and TMPRSS2 via acetylation of histone H2A.Z in prostate cancer cells.

O. Ukimura, F. Hongo, Saya Ito, 2018, Biochimica et biophysica acta. Gene regulatory mechanisms.

Androgen suppresses testicular cancer cell growth in vitro and in vivo

Terukazu Nakamura, T. Shiraishi, K. Kamoi, 2016, Oncotarget.

Predictive factors for the efficacy of abiraterone acetate therapy in high-risk metastatic hormone-sensitive prostate cancer patients

T. Shiraishi, K. Okihara, O. Ukimura, 2022, World Journal of Urology.

PAX2 promoted prostate cancer cell invasion through transcriptional regulation of HGF in an in vitro model.

Terukazu Nakamura, T. Shiraishi, T. Miki, 2015, Biochimica et biophysica acta.

Apalutamide versus bicalutamide in combination with androgen deprivation therapy for metastatic hormone sensitive prostate cancer

K. Okihara, A. Fujihara, Naruhiro Kayukawa, 2024, Scientific reports.